Sponsor Pipeline

NGM Biopharmaceuticals, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07033026 An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in… Colorectal Cancer Recruiting
Phase 1
NCT05215574 Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and… Pancreatic Cancer Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Prostate Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Kidney Cancer (1) Ovarian Cancer (1) Cervical Cancer (1) Melanoma (1)
Get alerts when NGM Biopharmaceuticals, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free